Dadun/></a>
				</td>
				<td class= Dadun
   (New user)
Help  | Contact  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Oncología > Terapia celular > DA - CIMA - Oncología - Terapia celular - Artículos de Revista >

RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements
Authors: Puig-Kröger, A. (Amaya)
Sanchez-Elsner, T. (Tilman)
Ruiz, N. (Natividad)
Andreu, E.J. (Enrique José)
Prosper, F. (Felipe)
Jensen, U. (U.B.)
Gil, J. (Juana)
Erickson, P. (P.)
Drabkin, H. (H.)
Groner, Y. (Y.)
Corbi, A.L. (Angel L.)
Keywords: Materias Investigacion::Ciencias de la Salud::Oncología
Issue Date: 2003
Publisher: American Society of Hematology
Publisher version: http://dx.doi.org/10.1182/blood-2003-02-0618
ISSN: 0006-4971
Citation: Puig-Kröger, A., Sanchez-Elsner, T., Ruiz, N., Andreu, E. J., Prosper, F.,Jensen, U. B. et al. RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements. Blood 2003; 102 (9): 3252-3261
Abstract
The CD11a/CD18 (leukocyte functionassociated antigen 1 [LFA-1]) integrin mediates critical leukocyte adhesive interactions during immune and inflammatory responses. The CD11a promoter directs CD11a/CD18 integrin expression, and its activity in lymphoid cells depends on a functional RUNX1/AML-1–binding site (AML-110) within the MS7 sequence. We now report that MS7 contains a C/EBPbinding site (C/EBP-100), which overlaps with AML-110 and is bound by C/EBP factors in myeloid cells. C/EBP and RUNX/ AML factors compete for binding to their respective cognate elements and bind to the CD11a promoter MS7 sequence in a cell lineage- and differentiation-dependent manner. In myeloid cells MS7 is primarily recognized by C/EBP factors in proliferating cells whereas RUNX/AMLfactors (especially RUNX3/AML-2) bind to MS7 in differentiated cells. RUNX3/AML-2 binding to the CD11a promoter correlates with increased RUNX3/AML-2 protein levels and enhanced CD11a/CD18 cell surface expression. The relevance of the AML-110 element is underscored by the ability of AML-1/ETO to inhibit CD11a promoter activity, thus explaining the low CD11a/CD18 expression in t(8;21)–containing myeloid leukemia cells. Therefore, the expression of the CD11a/CD18 integrin in myeloid cells is determined through the differential occupancy of the CD11a proximal promoter by transcription factors implicated in the pathogenesis of myeloid leukemia.
Permanent link: http://hdl.handle.net/10171/18733
Appears in Collections:DA - CIMA - Oncología - Síndromes mieloproliferativos - Artículos de Revista
DA - CIMA - Oncología - Terapia celular - Artículos de Revista
DA - CUN - Área de Terapia Celular - Artículos de revista
DA - Medicina - Hematología - Artículos de revista

Files in This Item:
File:  2003_Blood_Puig-Kroger_RUNX AML and C EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements.pdf
Description: 
Size:  361,76 kB
Format:  Adobe PDF
 View / Open 

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.